Delivery Order 36F79724D0176-36C25926F0264
Award Date 7/31/26
Potential Completion Date 8/31/26
Potential Value $385K
Federal Agency
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Horsham, PA 19044, USA
Solicitation Procedures
Multiple Award, Fair Opportunity
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The U.S. Department of Veterans Affairs, Veterans Integrated Service Network 19, awarded a $351,987.69 firm fixed-price delivery order to Janssen Biotech Inc. (doing business as Centocor Ortho Biotech Inc.) on December 16, 2025, for pharmacy purchases to be performed in Horsham, PA. This delivery order, with an ultimate completion date of January 16, 2026, carries no set-aside designation and is issued under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). Janssen Biotech, a...
- Veterans Integrated Service Network 5 issued a $22,508.03 delivery order to Merck Sharp & Dohme LLC on May 7, 2026, for pharmacy services under the Department of Veterans Affairs' Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The parent FSS-61-IB contract, awarded June 1, 2025, and extending through May 31, 2030, provides pharmaceutical and drug procurement across Veterans Integrated Service Networks. Place of performance is Carrollton, TX. The delivery order is priced...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $17,046 delivery order to Janssen Biotech, Inc. under the company's Pharmaceuticals and Drugs GSA Schedule contract. The order is for BALVERSA 4MG and will be fulfilled from July 18-20, 2023 with performance taking place in Carrollton, Texas. Janssen Biotech will provide the specified oncology drug to VA-VHA under a firm fixed price arrangement. As one of the largest health care...
- Veterans Integrated Service Network 5 issued a $31,040.96 delivery order to UCB Pharma, Inc. on July 10, 2026, for Zilbrysq 32.4 mg under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The order is firm fixed price with no set-aside. Place of performance is Pittsburgh, PA. Ultimate completion date is July 15, 2026. The Pharmaceuticals and Drugs FSS-61-IB is a GSA schedule providing pre-negotiated pricing for prescription medications to support VA acquisition nationwide.
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 awarded a $15,090.88 delivery order to Janssen Biotech, Inc. under the Pharmaceuticals and Drugs Federal Supply Schedule contract (FSS-61-IB) for BALVERSA 4 MG. The firm fixed price order is for the delivery of the specified pharmaceutical product to a location in Carrollton, Texas, with performance to be completed by November 13, 2020. No set-aside designation was applied to this order placed...
- <p>Veterans Integrated Service Network 20 issued a delivery order to Agios Pharmaceuticals, Inc. on July 15, 2026, with a ceiling value of $73,080.48 for a three-month pharmaceutical supply under the GSA Schedule Pharmaceuticals and Drugs (FSS-61-IB).</p> <p>Place of performance is Cary, NC. The order is firm fixed price with an ultimate completion date of October 15, 2026. No set-aside was used.</p>
- Janssen Biotech Inc., doing business as Centocor Ortho Biotech Inc., has been awarded a $17,642.95 firm fixed price delivery order from the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5 to provide BALVERSA 4 MG. The delivery order was placed against Janssen's multiple award GSA Schedule Pharmaceuticals and Drugs contract, also known as FSS-61-IB, which has no set-aside designation and expires in March 2024. As a manufacturer of pharmaceutical...
- The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 9 awarded a $283,555.92 delivery order to Novartis Pharmaceuticals Corp., doing business as NPS, for KYMRIAH CAR T cell therapy under the Pharmaceuticals and Drugs Federal Supply Schedule contract. The delivery order, which has no set-aside designation, is for emergency KYMRIAH CAR T cell therapy and has a completion date of January 21, 2021. The contract pricing is firm fixed price. The place...
- Janssen Biotech, Inc. was awarded a $17,046.33 delivery order against the Pharmaceuticals and Drugs Federal Supply Schedule by the Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 5. The firm fixed price order is for BALVERSA 4MG and has an anticipated completion date of April 6, 2023. No set-aside provisions were applied to this award issued under GSA Schedule contract FSS-61-IB. The place of performance will be Carrollton, TX 75010. This...
- <p>The Defense Logistics Agency issued a delivery order to Amerisourcebergen Drug Corp on April 13, 2026, for VYVGART 400 mg/20 mL vials with a ceiling value of $13,583.55.</p> <p>Place of performance is Conshohocken, PA. The order is due for ultimate completion by May 4, 2026. The delivery order is priced on a firm fixed-price basis and was issued without a set-aside.</p>
- Pharmaceuticals and Drugs (FSS-61-IB)Master GSA Schedule
- 36F79724D0176Federal Supply Schedule
- 36F79724D0176-36C25926F0264Delivery Order
Veterans Integrated Service Network 19 issued a delivery order to Janssen Biotech Inc. on July 31, 2026, with a ceiling value of $384,718.69 for emergency pharmacy supply of CARVYKTI under the Pharmaceuticals and Drugs Federal Supply Schedule (FSS-61-IB). The FSS-61-IB is a GSA-administered multiple-award federal supply schedule for pharmaceutical products. Place of performance is Horsham, PA. The order carries a firm fixed-price structure with an ultimate completion date of August 31, 2026.
Generated 7/31/26, 9:44 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $384.7k | 7/29/26 |